| Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ... Cell Death & Differentiation 25 (3), 486-541, 2018 | 5532 | 2018 |
| Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 G Kroemer, L Galluzzi, P Vandenabeele, J Abrams, ES Alnemri, ... Cell death & differentiation 16 (1), 3-11, 2009 | 4001 | 2009 |
| Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 L Galluzzi, I Vitale, JM Abrams, ES Alnemri, EH Baehrecke, ... Cell Death & Differentiation 19 (1), 107-120, 2012 | 3149 | 2012 |
| Stabilization of wild-type p53 by hypoxia-inducible factor 1α WG An, M Kanekal, MC Simon, E Maltepe, MV Blagosklonny, LM Neckers Nature 392 (6674), 405-408, 1998 | 1157 | 1998 |
| Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 L Galluzzi, BS Pedro, I Vitale, SA Aaronson, JM Abrams, D Adam, ... Cell Death & Differentiation 22 (1), 58-73, 2015 | 1155 | 2015 |
| Classification of cell death: recommendations of the Nomenclature Committee on Cell Death G Kroemer, W El-Deiry, P Golstein, ME Peter, D Vaux, P Vandenabeele, ... Cell death and differentiation 12, 1463-1467, 2005 | 1119 | 2005 |
| Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes L Galluzzi, SA Aaronson, J Abrams, ES Alnemri, DW Andrews, ... Cell Death & Differentiation 16 (8), 1093-1107, 2009 | 837 | 2009 |
| Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms V Sandor, S Bakke, RW Robey, MH Kang, MV Blagosklonny, J Bender, ... Clinical Cancer Research 8 (3), 718-728, 2002 | 676 | 2002 |
| The restriction point of the cell cycle MV Blagosklonny, AB Pardee Cell cycle 1 (2), 102-109, 2002 | 627 | 2002 |
| Disruption of the Raf-1-Hsp90 Molecular Complex Results in Destabilization of Raf-1 and Loss of Raf-1-Ras Association (∗) TW Schulte, MV Blagosklonny, C Ingui, L Neckers Journal of Biological Chemistry 270 (41), 24585-24588, 1995 | 569 | 1995 |
| Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway MV Blagosklonny, T Schulte, P Nguyen, J Trepel, LM Neckers Cancer research 56 (8), 1851-1854, 1996 | 549 | 1996 |
| Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death MV Blagosklonny, P Giannakakou, WS El-Deiry, DGI Kingston, PI Higgs, ... Cancer research 57 (1), 130-135, 1997 | 517 | 1997 |
| Molecular effects of paclitaxel: myths and reality (a critical review) MV Blagosklonny, T Fojo International journal of cancer 83 (2), 151-156, 1999 | 493 | 1999 |
| Aging: Ros or tor MV Blagosklonny Cell cycle 7 (21), 3344-3354, 2008 | 479 | 2008 |
| p53 is associated with cellular microtubules and is transported to the nucleus by dynein P Giannakakou, DL Sackett, Y Ward, KR Webster, MV Blagosklonny, ... Nature cell biology 2 (10), 709-717, 2000 | 462 | 2000 |
| Rapamycin decelerates cellular senescence ZN Demidenko, SG Zubova, EI Bukreeva, VA Pospelov, TV Pospelova, ... Cell cycle 8 (12), 1888-1895, 2009 | 445 | 2009 |
| Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition MV Blagosklonny Cell cycle 5 (18), 2087-2102, 2006 | 439 | 2006 |
| Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. MV Blagosklonny, J Toretsky, S Bohen, L Neckers Proceedings of the National Academy of Sciences 93 (16), 8379-8383, 1996 | 431 | 1996 |
| Growth stimulation leads to cellular senescence when the cell cycle is blocked ZN Demidenko, MV Blagosklonny Cell cycle 7 (21), 3355-3361, 2008 | 411 | 2008 |
| p53 inhibits hypoxia-inducible factor-stimulated transcription MV Blagosklonny, WG An, LY Romanova, J Trepel, T Fojo, L Neckers Journal of Biological Chemistry 273 (20), 11995-11998, 1998 | 407 | 1998 |
